Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4

BACKGROUND: The discovery of direct-acting antiviral agents (DAA) is an outstanding achievement of modern medicine in the current century. The current study aimed to explore the effectiveness and safety of two regimens sofosbuvir (SOF) in combination with either ribavirin (RBV) or simeprevir (SMV) i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Gastroenterol
Autores principales: Abdel-Moneim, Adel, Aboud, Alaa, Abdel-Gabbar, Mohamed, Zanaty, Mohamed I., Elbary, Amr A. Abd, Ramadan, Mohamed
Formato: Artigo
Lenguaje:Inglês
Publicado: Hellenic Society of Gastroenterology 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302204/
https://ncbi.nlm.nih.gov/pubmed/30598598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2018.0327
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares